Jacobs Levy Equity Management
YARW

Jacobs Levy Equity Management’s Yarrow Bioscience YARW Stock Holding History

Jacobs Levy Equity Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-225
Closed -$1.28M – 1124
2020
Q4 		$1.28M Buy
225
+109
+94% +$685K 0.01% 665
2020
Q3 		$694K Buy
116
+50
+76% +$292K 0.01% 726
2020
Q2 		$411K Buy
66
+52
+371% +$352K ﹤0.01% 820
2020
Q1 		$132K Sell
14
-2
-13% -$31.4K ﹤0.01% 938
2019
Q4 		$265K Sell
16
-4
-20% -$66.7K ﹤0.01% 883
2019
Q3 		$324K Sell
20
-12
-38% -$194K ﹤0.01% 769
2019
Q2 		$684K Buy
32
+3
+10% +$74.2K 0.01% 696
2019
Q1 		$823K Buy
29
+2
+7% +$48K 0.01% 702
2018
Q4 		$399K Buy
+27
New +$604K 0.01% 773

Other funds holding YARW

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Jacobs Levy Equity Management's YARW Position: Q1 2021 in Review

Jacobs Levy Equity Management sold out of Yarrow Bioscience (YARW) in Q1 2021, closing a stake of 225 shares — an estimated $1.28M sold.

Jacobs Levy Equity Management first reported a position in YARW in Q4 2018 and held it in 9 quarters. The position peaked at $1.28M in Q4 2020. 81 funds tracked by Wall St. Rank hold YARW as of Q1 2021.

  • Jacobs Levy Equity Management reported no remaining Yarrow Bioscience position as of Q1 2021 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 225 Yarrow Bioscience shares in Q1 2021, an estimated $1.28M.
  • Jacobs Levy Equity Management first reported a position in Yarrow Bioscience in Q4 2018 and held it in 9 quarters.
  • Jacobs Levy Equity Management's Yarrow Bioscience position peaked at $1.28M in Q4 2020.
  • 81 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2021, filed 17 May 2021.